Rasmus Siersbæk (@rsiersbaek) 's Twitter Profile
Rasmus Siersbæk

@rsiersbaek

Molecular Cancer Biologist

ID: 1152925571195781121

calendar_today21-07-2019 12:57:31

533 Tweet

509 Takipçi

459 Takip Edilen

Rasmus Siersbæk (@rsiersbaek) 's Twitter Profile Photo

... and you can find a summary of our findings on MYC enhancer activity in cancer in this short research briefing now out Nature Genetics 😀 rdcu.be/dBct7

... and you can find a summary of our findings on MYC enhancer activity in cancer in this short research briefing now out <a href="/NatureGenet/">Nature Genetics</a> 😀
rdcu.be/dBct7
Kræftens Bekæmpelse (@cancer_dk) 's Twitter Profile Photo

Vigtig afgørelse på vej for kvinder med særlig form for uhelbredelig brystkræft. Vi, Brystkræftforeningen og lægelige fagfolk håber, at #medicinrådet godkender lægemiddel med dokumenteret effekt. #sundpol cancer.dk/nyheder-og-for…

SDU Science (@natsdu) 's Twitter Profile Photo

I de fleste kræftceller er der en overaktivitet af proteinet MYC. Rasmus Siersbæks forskningsgruppe fortæller nu i Nature Genetics om en hidtil ubemærket funktion af MYC, som potentielt kan hæmmes, så kræftcellerne svækkes 👊sdu.dk/da/om_sdu/faku…

Zwartlab_NKI (@zwartlab) 's Twitter Profile Photo

📢Save the date! EMBO Workshop Nuclear Receptors: No Disease is Safe 23–26 September 2024 | Cavtat, Croatia details on program and invited speakers will be announced asap 😀 Sign up below, so that you get the latest updates! 👇👇👇 coming-soon.embo.org/w24-114

Walid Khaled (@wtklab) 's Twitter Profile Photo

I am pleased to share the final version of our Human Breast Cell Atlas with MarioniLab now out Nature Genetics. There are important new additions, which I will leave to Sara Pensa and Austin Reed to mention👇 . Couple of points i want to highlight 👇: nature.com/articles/s4158…

Andrés Hidalgo (@andrshidalgo16) 's Twitter Profile Photo

An anniversary review on the Hallmarks of #cancer as a systemic disease, now Cell. An effort led by Charles Swanton Elsa Bernard and written together with many wonderful colleagues. authors.elsevier.com/c/1iqgjL7PXqPxO

An anniversary review on the Hallmarks of #cancer as a systemic disease, now <a href="/CellCellPress/">Cell</a>.
An effort led by <a href="/CharlesSwanton/">Charles Swanton</a> <a href="/Elsa2Bernard/">Elsa Bernard</a>  and written together with many wonderful colleagues.

authors.elsevier.com/c/1iqgjL7PXqPxO
Jan-Wilhelm Kornfeld 🇺🇦🇮🇱🇵🇸 (@kornfeld_janw) 's Twitter Profile Photo

Dear Friends and Collegues, we are still hiring for this exciting Novo Nordisk Foundation postdoc project (3 years) SDU Science Functional Genomics & Metabolism Research Unit to investigate microRNA mediated gene regulation in Cardiometabolic Diseases. Please help us share 🔀 and find our next collegue 🙏 👩‍🔬 👨‍🔬

Mathieu Lupien (@matlupien) 's Twitter Profile Photo

10 years after discovering the first cancer arising from chromatin as opposed to genetic variants (pubmed.ncbi.nlm.nih.gov/24553142/) a new study provides further evidence that cancer development can arise solely from chromatin variants. pubmed.ncbi.nlm.nih.gov/38658752/

Maxim Greenberg (@maxvcg) 's Twitter Profile Photo

How about this: Eliminate the job "post-doc". After a PhD you are a "researcher", and no punishment for multiple stops. At any point (age blind) you can apply for starting grant funds. You apply for consolidator funds w/in 7 years of starting lab (unlinked to PhD date).